New transplant combo targets tough leukemia
Disease control
Recruiting now
This study tests a stronger chemotherapy combination (thiotepa, busulfan, fludarabine) before a stem cell transplant for people with an aggressive form of chronic myelomonocytic leukemia (CMML). The goal is to see if this approach helps patients live longer without the cancer com…
Phase: PHASE4 • Sponsor: Sun Yuqian • Aim: Disease control
Last updated May 26, 2026 12:04 UTC